Kaili Du

Dr. Kaili Du


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
KDKaili Du
Kaili Du
XNXiaoyu Ning
Xiaoyu Ning
YHYongze Han
Yongze Han
XJXiaoyu Jiang
Xiaoyu Jiang
ZWZhuoyi Wang
Zhuoyi Wang
KYKeming Yun
Keming Yun
Fentanyl abuse has been associated with neurological and psychological harm. However, the metabolic changes within the peripheral circulation and central nervous system involved in fentanyl addiction have not been well explored. In the present study, metabolic changes in plasma, caudate putamen (CPu), hippocampus (Hip), and prefrontal cortex (PFC) were investigated in mouse models of drug addiction based on fentanyl-induced conditioned place preference (CPP). Metabolic profiles were measured using untargeted UHPLC-Q-Exactive HFX mass spectrometry. A total of 131, 196, 104, and 52 altered metabolites were identified in plasma, CPu, Hip, and PFC, respectively. The identified metabolites mainly included lipid mediators, carbohydrate metabolites, fatty acids, amino acids (AAs) and their derivatives, and nucleotide metabolites. The disturbed metabolic pathways were primarily involved in lipid metabolism, carbohydrate metabolism, AA metabolism, nucleotide metabolism, and the metabolism of cofactors and vitamins. These findings indicate disturbances in cell membrane metabolism, energy metabolism, AA metabolism, and neurotransmitter systems caused by fentanyl addiction. Our study provides a valuable resource for future investigations aimed at defining the role of metabolites in fentanyl addiction, which may help develop new pharmacotherapies.